-
-
Clinical perspectives on MAVENCLAD® (cladribine 10mg tablets), for highly active relapsing multiple sclerosis (MS), and real-world experiences from members of the multidisciplinary MS team
-
Posted in Sponsored Feature,Supplements
-
07th May 2019
-
This article was initiated, developed and funded by Merck